Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)

SHE:300760 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	16,644	18,787	23,186	15,361	15,865
Cash & Short-Term Investments	16,644	18,787	23,186	15,361	15,865
Cash Growth	-11.41%	-18.97%	50.94%	-3.17%	11.15%
Accounts Receivable	3,226	3,297	2,661	1,790	1,539
Other Receivables	205.53	195.1	149.11	126.04	279.03
Receivables	3,475	3,534	2,842	1,943	1,842
Inventory	4,757	3,979	4,025	3,565	3,617
Prepaid Expenses	59.71	60.57	92.31	58.1	123.87
Other Current Assets	709.96	515.29	461.19	407.58	183.29
Total Current Assets	25,647	26,875	30,606	21,335	21,632
Property, Plant & Equipment	10,035	8,221	6,290	5,131	4,129
Long-Term Investments	395.37	3,087	1,617	4,026	4,026
Goodwill	11,093	5,062	4,403	4,218	1,225
Other Intangible Assets	6,723	2,225	1,977	2,061	1,145
Long-Term Accounts Receivable	22.86	10.94	25.28	34.55	3.32
Long-Term Deferred Tax Assets	1,697	1,313	755.08	596.43	501.89
Long-Term Deferred Charges	406	417.23	379.45	224.24	204.16
Other Long-Term Assets	504.29	604	590.95	376.65	337.3
Total Assets	56,644	47,940	46,745	38,103	33,306
Accounts Payable	2,793	2,690	2,291	2,281	1,500
Accrued Expenses	3,253	3,049	3,136	2,428	2,063
Short-Term Debt	5.4	7.75	-	-	-
Current Portion of Long-Term Debt	1.16	0.43	-	-	-
Current Portion of Leases	114.27	104.3	97.22	85.08	-
Current Income Taxes Payable	205.43	471.65	287.22	256.75	136.31
Current Unearned Revenue	2,166	1,974	4,143	2,408	3,293
Other Current Liabilities	1,889	1,804	1,816	1,170	1,244
Total Current Liabilities	10,427	10,103	11,770	8,629	8,236
Long-Term Debt	0.34	1.38	-	-	-
Long-Term Leases	177.31	181.07	139.31	152.15	-
Long-Term Unearned Revenue	127	109.31	92.94	105.09	156.79
Long-Term Deferred Tax Liabilities	808.7	168.36	183.13	200.44	46.62
Other Long-Term Liabilities	4,345	4,031	2,561	2,048	1,576
Total Liabilities	15,885	14,594	14,746	11,135	10,016
Common Stock	1,212	1,212	1,212	1,216	1,216
Additional Paid-In Capital	6,752	7,091	7,509	8,153	8,153
Retained Earnings	28,229	25,288	24,369	18,994	14,032
Treasury Stock	-337.77	-663.28	-999.99	-999.99	-
Comprehensive Income & Other	1.51	157.27	-109.07	-409.74	-122.58
Total Common Equity	35,856	33,085	31,981	26,953	23,278
Minority Interest	4,902	260.65	18.29	15.24	12.75
Shareholders' Equity	40,758	33,346	31,999	26,968	23,290
Total Liabilities & Equity	56,644	47,940	46,745	38,103	33,306
Total Debt	298.49	294.93	236.52	237.24	-
Net Cash (Debt)	16,346	18,492	22,949	15,124	15,865
Net Cash Growth	-11.61%	-19.42%	51.74%	-4.67%	11.15%
Net Cash Per Share	13.49	15.26	18.96	12.45	13.05
Filing Date Shares Outstanding	1,210	1,214	1,209	1,213	1,216
Total Common Shares Outstanding	1,210	1,214	1,209	1,213	1,216
Working Capital	15,219	16,773	18,836	12,706	13,395
Book Value Per Share	29.64	27.25	26.44	22.23	19.15
Tangible Book Value	18,040	25,799	25,601	20,673	20,908
Tangible Book Value Per Share	14.91	21.25	21.17	17.05	17.20
Land	5,978	4,799	3,662	3,259	2,876
Machinery	4,149	3,283	2,822	2,366	1,924
Construction In Progress	2,675	2,461	1,803	1,126	929.84

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.